60 yr old female known SHTN came with dyspnea for 1 day and pedal edema for 1 week

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Loading Image
Now I have comprehensive information. Let me compile a thorough clinical response.

Clinical Case Analysis: 60F with SHTN, Dyspnea (1 day) + Pedal Edema (1 week)

Most Likely Diagnosis

Acute Decompensated Heart Failure (ADHF) - most likely HFpEF (Heart Failure with Preserved Ejection Fraction) secondary to hypertensive heart disease.
The classic triad:
  • Known systemic hypertension - the primary underlying cause
  • Pedal edema for 1 week - gradual volume overload (backward failure)
  • Acute dyspnea for 1 day - acute decompensation with pulmonary congestion
This is the "Typical Hypertensive" ADHF phenotype - usually not volume overloaded as much as fluid redistributed, and elevated BP at presentation is the driver.

Pathophysiology

Chronic hypertension leads to:
  1. Concentric LV hypertrophy - increased wall thickness, reduced compliance
  2. Diastolic dysfunction - impaired LV relaxation and filling
  3. HFpEF - elevated filling pressures despite preserved EF
  4. Any precipitant (salt load, medication non-compliance, new arrhythmia) tips the patient into acute decompensation with pulmonary edema and peripheral fluid redistribution

History to Elicit

Cardiac symptoms:
  • Orthopnea (number of pillows), PND, bendopnea
  • Chest pain/palpitations (rule out ACS, AF as precipitant)
  • Previous similar episodes / prior HF diagnosis
Precipitating factors:
  • Medication non-adherence (antihypertensives, diuretics)
  • Dietary salt excess
  • Use of NSAIDs, thiazolidinediones, cold/flu preparations
  • Recent febrile illness or infection
  • Reduced urine output
Background:
  • Duration and control of hypertension
  • DM, CKD, CAD, valvular disease
  • Alcohol, smoking

Examination

FindingSignificance
BP (elevated or low?)Hypertensive ADHF vs low-output state
HR, SpO2, RRHemodynamic severity
JVP elevatedRight-sided congestion
Basal crepitationsPulmonary edema
S3 gallopVentricular dysfunction
Pitting pedal edemaVolume overload
HepatomegalyCongestion
Loud P2Pulmonary hypertension

Investigations

Immediate:
  • ECG - LVH, arrhythmia (AF), ischemia
  • CXR - cardiomegaly, pulmonary venous congestion, Kerley B lines, pleural effusion
  • BNP / NT-proBNP - class I recommendation for diagnosis of acute HF; highly elevated in ADHF (BNP >100 pg/mL, NT-proBNP >300 pg/mL)
  • SpO2 / ABG - degree of hypoxia
  • CBC - anemia as precipitant
  • RFT (Creatinine, BUN, electrolytes) - cardiorenal syndrome (BUN >43 mg/dL and Cr >2.75 mg/dL are markers of worse prognosis)
  • LFT - hepatic congestion
  • Blood glucose, HbA1c - DM comorbidity
  • Troponin - rule out ACS as precipitant
Non-urgent:
  • Echocardiography - most important: assess EF (HFrEF vs HFpEF), LVH, diastolic dysfunction grading, valvular disease, wall motion abnormalities
  • Thyroid function (hyperthyroidism as precipitant)

Management

Phenotype Classification (This Patient)

Given known hypertension and this presentation, she most likely fits the "Hypertensive ADHF" phenotype (BP elevated, fluid redistribution rather than pure volume overload):
ADHF Management Phenotypes
ADHF phenotypes and treatment approach - Harrison's Principles of Internal Medicine 22e

Step 1 - Immediate stabilization

  • Sit upright (reduces preload)
  • Supplemental O2 to maintain SpO2 ≥94%
  • Noninvasive ventilation (CPAP/BiPAP) if severe pulmonary edema / respiratory distress

Step 2 - Pharmacotherapy

DrugDoseRationale
IV Furosemide40 mg IV (or 1-2.5x oral dose)First-line decongestant; bolus vs infusion - no clear difference in trials
IV Nitrates (GTN/nitroglycerine)SL or IV infusionVasodilator of choice in hypertensive ADHF - reduces preload AND afterload, relieves dyspnea, lowers BP
IV NitroprussideIf severe hypertensive emergencyMore potent vasodilator for refractory hypertension
  • For diuretic resistance: add metolazone or chlorothiazide (sequential nephron blockade) - watch for hypokalemia
  • Avoid: ACEi/ARB/beta-blocker initiation during acute decompensation if hemodynamically unstable

Step 3 - Monitor response

  • Weight daily (surrogate for fluid status)
  • JVP, edema, pulmonary crackles normalization
  • Urine output >0.5 mL/kg/hr
  • Renal function (cardiorenal syndrome in ~30%)
  • Pre-discharge BNP/NT-proBNP - elevated level at discharge = high readmission risk

Step 4 - Address precipitants

Per Harrison's 22e, always identify and treat:
  • Medication non-adherence
  • Dietary indiscretion (salt)
  • Concurrent infection
  • AF or other arrhythmia
  • Myocardial ischemia (ECG, troponins, stress test)
  • Valvular disease (echo)

Discharge and Long-Term Management

Drug ClassAgentIndication
ACE inhibitor/ARB/ARNiRamipril, Sacubitril-valsartanBP control, neurohormonal blockade
Beta-blockerMetoprolol, CarvedilolAfter euvolemia achieved
MRASpironolactoneIf HFrEF or HFpEF with persistent congestion
Loop diureticOral furosemide/torsemideMaintenance decongestion
SGLT2iEmpagliflozin/DapagliflozinProven mortality benefit in both HFrEF and HFpEF
Salt restriction (<2g/day), fluid restriction, daily weight monitoring, and BP targets (<130/80 mmHg) are essential.

Differential Diagnoses to Consider

DiagnosisFeatures distinguishing from HF
Pulmonary embolismSudden dyspnea, pleuritic pain, DVT, D-dimer, CTPA
Bilateral pleural effusion (non-cardiac)Hepatic/renal cause; BNP normal
PneumoniaFever, cough, consolidation on CXR, WBC elevated
CKD with fluid overloadUremic symptoms, frothy urine, very elevated creatinine
Hypertensive emergency with pulmonary edemaSevere HTN + organ damage

Key Prognostic Markers (ADHF)

Parameters associated with worse outcomes (Harrison's 22e):
  • BUN >43 mg/dL
  • Systolic BP <115 mmHg at presentation
  • Creatinine >2.75 mg/dL
  • Elevated troponins and natriuretic peptides
  • Residual congestion at discharge
The 30-day readmission rate for ADHF is nearly 25%, and 1-year combined CV events reach 50% - making thorough in-hospital management and post-discharge follow-up critical.

Sources: Harrison's Principles of Internal Medicine 22e; Brenner & Rector's The Kidney; Fuster & Hurst's The Heart, 15th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.